Weiterführende Literatur
Ramos de Siqueira F, Carneiro de Oliveira K, Vasques Dominguez W, Madid Truyts CA, Affonso Moysés RM, Machado Dos Reis L, Jorgetti V (2021) Effect of parathyroidectomy on bone tissue biomarkers and body composition in patients with chronic kidney disease and secondary hyperparathyroidism. Eur J Clin Nutr. https://doi.org/10.1038/s41430-020-00829-7
Chen S, Sheng K, Shen Y, Jiang H, Lei X, Qu L, Xu C, Chen J, Zhang P (2020) Impact of parathyroidectomy on left ventricular function in end stage renal disease patients. BMC Nephrol 21(1):479. https://doi.org/10.1186/s12882-020-02139-3
Dulfer RR, Koh EY, van der Plas WY, Engelsman AF, Nieveen van Dijkum EJM, Pol RA, Vogt L, de Borst MH, Kruijff S, Schepers A, Appelman-Dijkstra NM, Rotmans JI, Hesselink DA, van Eijck CHJ, Hoorn EJ, van Ginhoven TM, Dutch Hyperparathyroid Study Group (2019) Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis. Langenbecks Arch Surg 404(1):71–79. https://doi.org/10.1007/s00423-019-01755-4
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Fischereder gibt an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
T. Feldkamp, Hann. Münden
J. Lutz, Koblenz
L.T. Weber, Köln
Rights and permissions
About this article
Cite this article
Fischereder, M. Behandlung des sekundären Hyperparathyreoidismus bei Dialysepatienten und Transplantationserfolg. Nephrologe 16, 235–236 (2021). https://doi.org/10.1007/s11560-021-00501-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11560-021-00501-6